KN Hospital 02120Prospectus Information

Prospectus & Stock Connect
Company Overview
Stock NameKN Hospital
Stock Code02120
Company Full NameTo be extracted
Industry醫療保健
Principal Activities主要於中國從事經營精神科醫院、提供醫院管理服務,以及從事房地產業務。
Listing Date2015-11-20
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國浙江省溫州市黃龍住宅區盛錦路
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.knhosp.cn
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 38.70 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone Share9.5%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 340,560,000
Stock Connect Inclusion
HK Market Cap ---
26Q2 Regular Review
Inclusion Pathway None
Est. Threshold ---
Analysis Result 无法确定入通路径
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 49.1
First Day OpenHK$ 44.0
First Day Change26.87%
First Day Volume13746900.0
First Day Turnover640369000.0
Use of Proceeds
Use of Proceeds1、約50%或305.6百萬港元將用于通過我們多元化的擴張模式在精神科醫療服務供不應求的地區擴張及提升我們的醫療機構網絡及包括我們現有及未來發展中的機構在內的運營能力; 2、約25%或152.8百萬港元將用于溫州康寧醫院的改造及升級項目,以擴張其運營規模及高端醫療服務能力; 3、約10%或61.1百萬港元將用于科研、教學及人員培訓用途,包括擴大我們與經挑選的國內外精神科醫療機構及大學的合作; 4、約8%或48.9百萬港元將用于發展我們的移動和在線醫療咨詢平臺并改進我們的信息科技基礎設施,而我們相信這將進一步提升我們的品牌知名度及患者覆蓋能力; 5、約7%或42.8百萬港元將用作營運資金及其他一般企業用途。
Underwriting Syndicate
Joint Sponsors (2)
Citigroup Global Markets Asia Limited CE AAA137 中信证券(香港)有限公司 CE AAK249
Overall Coordinators (2)
Citigroup Global Markets Asia Limited CE AAA137 中信里昂证券有限公司 CE AAB893
Joint Bookrunners (3)
Citigroup Global Markets Asia Limited CE AAA137 Citigroup Global Markets Asia Limited CE AAA137 中信里昂证券有限公司 CE AAB893
Joint Lead Managers (3)
Citigroup Global Markets Asia Limited CE AAA137 Citigroup Global Markets Asia Limited CE AAA137 中信里昂证券有限公司 CE AAB893
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Dragon Billion China Master Fund 108,507,060 HKD — 4.40% — 6 months 2016-05-20
2 OrbiMed Funds 139,509,630 HKD — 5.10% — 6 months 2016-05-20
Directors & Management
Chairman管偉立
Company Secretary黃偉超;王健
No director data available.
Major Shareholders
Major Shareholders & Holdings管偉立(29.68%);王紅月(11.32%);上海盛歌投資管理有限公司(8.72%);Guangzhou GL Capital Investment Fund L.P.(7.22%)
// About this page //

This page shows KN Hospital (02120) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements.

Disclaimer

Site Nature: This website (cibo.hk) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect